Primary Site >> Esophagus Cancer

Gene >> SERPINE1

  • 1994
  • 1997
  • 1998
  • 2001
  • 2002
  • 2004
  • 2006
  • 2012
  • 2016
Ref: Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
PMID: 7780225
 Ref: [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation].
PMID: 9121003
 Ref: Strong prognostic impact of tumor-associated urokinase-type plasminogen activator in completely resected adenocarcinoma of the esophagus.
PMID: 9676852
 Ref: Serine proteinase activation in esophageal cancer.
PMID: 11724279
 Ref: Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma.
PMID: 12530017
 Ref: Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma.
PMID: 15736404
 Ref: PAI-1 expression levels in esophageal and colorectal cancers are closely correlated to those in corresponding normal tissues.
PMID: 17201153
 Ref: Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis.
PMID: 23238211
 Ref: Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.
PMID: 27895782